Calprotectin Test: Safety, Meaning & What High Levels Mean in Pregnancy
This guide explains the calprotectin stool test, a gut-specific marker for intestinal inflammation. It covers the test's complete safety during... Read more
Author: InnerBuddies
Updated:
Inflammatory marker testing measures key proteins and immune signals—such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and pro-inflammatory cytokines—that reveal hidden inflammation in the body. Because chronic inflammation often develops silently, this testing provides early insight long before symptoms become severe.
Research consistently links elevated inflammatory markers to digestive disorders, cardiovascular risk, and autoimmune conditions. The gut microbiome plays a central role here: imbalanced bacteria can trigger low-grade systemic inflammation that shows up clearly on lab work.
Common markers measured include:
Pairing inflammatory marker testing with a gut microbiome test creates a far more complete diagnostic picture, revealing whether microbial imbalance is fueling immune activation. For individuals tracking recovery, longitudinal testing through a gut microbiome test subscription helps confirm whether dietary and lifestyle changes are genuinely lowering inflammation over time.
Clinicians, labs, and wellness brands can integrate these diagnostics at scale through a B2B gut microbiome platform. Whether you are investigating unexplained fatigue, digestive discomfort, or optimizing patient outcomes, inflammatory marker testing offers an evidence-based foundation for smarter, earlier health decisions—especially when combined with deeper insights into the gut.
This guide explains the calprotectin stool test, a gut-specific marker for intestinal inflammation. It covers the test's complete safety during... Read more
This blog explains calprotectin test timing to support accurate stool-based testing for gastrointestinal inflammation and better digestive health assessment. It... Read more
ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data
Persistent fatigue, unexplained bloating, joints that ache for no obvious reason — and blood work that comes back "normal," or slightly flagged with no explanation. This frustrating gap between how you feel and what standard tests show is remarkably common. Inflammatory marker testing is often the first step doctors use to detect inflammation in the body, and it can offer genuinely valuable clues. But these markers typically reveal only that inflammation may be present — rarely where it comes from or why. This article explains what inflammatory markers measure, why results vary so much between people, and how your gut microbiome may hold the missing context behind chronic inflammation symptoms.
Inflammatory marker testing refers to a group of blood and stool tests that measure substances released as part of the immune response. When tissue is injured, infected or irritated, the immune system produces signaling molecules that trigger a measurable cascade — some of which circulate in the blood or accumulate in the gut. Doctors order these tests to screen for inflammation when symptoms are vague, to monitor known conditions over time, and to help rule possibilities in or out.
Acute inflammation — the kind that follows an infection or injury — produces clear marker spikes that are easy to detect. Chronic low-grade inflammation is different: it often simmers beneath the detection threshold of standard tests. This is why "borderline" results are common and frequently dismissed, even though research suggests this smoldering type of immune activation may be involved in a wide range of long-term health concerns.
An estimated 70% of the body's immune tissue resides in and around the gut. The digestive tract is not just a digestion organ — it is a central hub of immune surveillance, constantly deciding which substances to tolerate and which to react against.
The intestinal lining forms a thin but crucial barrier that absorbs nutrients while keeping microbes and their by-products contained. When barrier function becomes compromised — sometimes described as increased intestinal permeability — microbial components may cross into circulation and potentially contribute to immune activation elsewhere in the body.
Inflammation can disrupt digestion, and gut disturbances can fuel inflammation. This bidirectional relationship helps explain why digestive complaints and systemic symptoms so often appear together — and why looking only at blood markers may capture only half the picture.
Bloating, abdominal discomfort, irregular bowel habits and new food sensitivities are among the most frequently reported digestive signs. Because inflammatory signaling travels throughout the body, chronic inflammation symptoms often extend beyond the gut — persistent fatigue, brain fog, joint aches, skin flare-ups and low mood are commonly described.
Occasional bloating or a tired week is normal. Symptoms become more meaningful when they persist for weeks, cluster together, or interfere with daily life. One important note: sudden, severe or worsening symptoms — such as blood in the stool, unexplained weight loss or intense abdominal pain — always warrant prompt medical evaluation first.
Laboratory reference ranges are calculated from large population samples. A result within the range is not necessarily optimal for you specifically — and a result just outside it does not automatically signal disease.
This variability creates a well-known clinical grey zone. Some people show mildly elevated inflammatory markers with no obvious cause; others report significant symptoms while their results stay firmly "normal." Studies of conditions like irritable bowel syndrome show that many people with genuine, disruptive symptoms have CRP levels within reference ranges. A normal result makes certain types of overt inflammation less likely — but it does not rule out immune imbalance or gut dysbiosis occurring at a level blood tests cannot reach.
Bloating can stem from dietary patterns, stress, hormonal shifts, enzyme deficiencies or microbial imbalances. Fatigue maps to an even longer list. Symptoms are signals — but rarely specific ones.
Without objective data, the default response is trial and error: eliminating food groups, rotating supplements, hoping something works. This approach costs time and money, and overly restrictive diets may even reduce microbial diversity further.
To move from symptom management toward root-cause understanding, it helps to look upstream — to the ecosystem where trillions of microbes interact with the majority of your immune system every day.
Gut microbes are not passive residents. They produce metabolites that interact directly with immune cells, helping "train" the immune system to distinguish friend from foe. A well-balanced ecosystem tends to promote immune tolerance; an imbalanced one has been associated with heightened reactivity.
When beneficial bacteria ferment dietary fiber, they produce short-chain fatty acids — most notably butyrate. Butyrate serves as the primary energy source for the cells lining the colon, supports gut barrier integrity, and has been associated with anti-inflammatory signaling in research settings.
Gut dysbiosis — a disruption in the composition or function of the microbiome — can shift this balance. Certain bacterial groups carry lipopolysaccharides (LPS) on their outer membranes; when the barrier is impaired, LPS translocation may stimulate immune activation. Evidence indicates dysbiosis is frequently observed alongside inflammatory conditions such as IBS and IBD, and has been linked with metabolic and autoimmune-type inflammatory profiles — though association is not proof of causation, and this remains an active area of research. Most scientists currently favor a vicious-cycle model in which dysbiosis and inflammation reinforce one another.
Reduced microbial diversity is one of the most consistent findings associated with inflammatory profiles across studies. A less varied ecosystem tends to be less resilient and less functionally versatile.
Depletion of butyrate-producing bacteria — such as Faecalibacterium and Roseburia — is commonly reported in research on inflammatory and metabolic conditions, potentially weakening both the gut lining and anti-inflammatory signaling.
Conversely, expansion of certain potentially harmful bacterial groups has been correlated with elevated inflammatory markers and compromised barrier function in some studies.
Critically, there is no single "inflammatory microbiome." Two people with nearly identical symptoms can carry completely different imbalances — one low in butyrate producers, another with overgrowth of a specific strain. This is precisely why generic protocols so often disappoint, and why personalized gut health matters.
A CRP test, ESR and related markers answer the question "is there inflammation, and how intense is it right now?" They provide a snapshot of the "what" — presence and intensity — but not the underlying driver.
A gut microbiome test analyzes the composition of your gut ecosystem. Depending on the analysis, it may reveal:
Inflammatory markers help answer whether inflammation may be occurring; microbiome analysis helps explore why — which upstream imbalances might be contributing. Used together, they build a fuller picture than either alone. Importantly, microbiome testing is an educational and insight-generating tool: it is not a medical diagnosis and does not replace professional evaluation.
Red-flag symptoms — bleeding, significant weight loss, fever or severe pain — should always prompt a doctor's visit first. Microbiome testing complements medical care; it does not substitute for it.
Honest science requires acknowledging what microbiome testing cannot do:
Because the microbiome can change over time — often within weeks of dietary change — some people choose longitudinal testing, such as a gut health membership that supports tracking microbiome changes over time, to see whether adjustments are genuinely shifting their ecosystem in a meaningful direction.
The most informative approach pairs conventional medical testing — blood markers and, where appropriate, fecal calprotectin — with microbiome analysis, ideally reviewed together with a qualified healthcare provider.
After testing, practical next steps typically involve personalized dietary adjustments (for example, increasing diverse fiber sources to support short-chain fatty acid production), targeted prebiotic or probiotic strategies, and stress and sleep optimization — followed by retesting to see what actually changed. Measurement turns guesswork into a feedback loop.
Inflammatory marker testing measures substances the body releases during an immune response, most commonly through blood tests such as CRP and ESR, and through stool tests such as fecal calprotectin. These tests help detect whether inflammation is present and how active it appears to be.
Elevated CRP indicates that inflammation is occurring somewhere in the body, but the test cannot identify its source. Causes range from minor infections and vigorous exercise to chronic conditions, which is why results should always be interpreted by a healthcare professional in context.
Yes. Low-grade chronic inflammation can persist below the detection thresholds of standard blood tests. Many people with genuine digestive symptoms have normal CRP and even normal fecal calprotectin, which is why additional context — such as microbiome analysis — can be useful.
Fecal calprotectin is a protein released by immune cells in the intestinal lining. Elevated levels in stool suggest intestinal inflammation and can help doctors distinguish inflammatory bowel disease from functional conditions like IBS.
Gut bacteria communicate with immune cells through metabolites such as short-chain fatty acids. Beneficial compounds like butyrate support the gut barrier and have been associated with anti-inflammatory signaling, while dysbiosis may promote immune activation through mechanisms such as LPS translocation.
Gut dysbiosis describes an imbalance in the composition or function of the gut microbiome — for example, reduced diversity, depletion of beneficial species, or expansion of potentially harmful ones. Research has linked dysbiosis with a range of digestive and inflammatory conditions, though cause-and-effect relationships are still being studied.
A microbiome test can show your overall microbial diversity, the balance of anti-inflammatory versus pro-inflammatory bacterial groups, your microbiome's functional potential such as butyrate production capacity, and the presence of bacteria associated with gut inflammation in research studies.
No. Microbiome testing is an educational and insight-generating tool. It describes the composition and functional potential of your gut ecosystem but does not diagnose any medical condition. Diagnosis requires a qualified healthcare professional.
Yes. The microbiome is dynamic and can shift noticeably within days to weeks in response to diet, stress, sleep, travel and medications. This is why a single test is a snapshot, and why some people choose to retest periodically.
Microbiome composition is shaped by genetics, diet, environment, medication history and lifestyle, and it varies enormously between individuals. Identical symptoms can arise from entirely different microbial imbalances, which is one reason one-size-fits-all interventions often fail.
Research suggests that dietary patterns rich in diverse fibers and fermented foods can increase microbial diversity and short-chain fatty acid production, which have been associated with healthier inflammatory profiles in some studies. However, individual responses vary, and anyone with a medical condition should make changes with professional guidance.
Yes, especially if you have severe, sudden or worsening symptoms such as blood in the stool, unexplained weight loss or intense pain. Microbiome testing is best used alongside — not instead of — conventional medical evaluation.
Inflammatory marker testing answers an important first question — whether inflammation may be present and how strong the signal is. But on its own, it rarely explains why. Results vary between individuals, symptoms do not map neatly onto causes, and chronic low-grade inflammation can hide below standard detection thresholds. Increasingly, research points upstream, to the gut ecosystem where most of the immune system and trillions of microbes interact every day.
The essential insight is that inflammation is personal — and so is your microbiome. Two people can share identical symptoms yet carry completely different imbalances, which is why guessing so often keeps people stuck. Understanding your unique gut microbiome, through a microbiome test and in partnership with your healthcare provider, replaces speculation with a starting point: a personalized map of what may be happening in your gut, and a baseline for tracking meaningful change over time.
inflammatory marker testing, high inflammatory markers, chronic inflammation symptoms, normal inflammatory markers but still symptoms, gut microbiome and inflammation, gut dysbiosis, fecal calprotectin, CRP test, gut microbiome test, chronic low-grade inflammation, microbial diversity, butyrate, short-chain fatty acids, intestinal permeability, personalized gut health
Full microbiome sequencing + Gut Health Index. Metabolic pathways, diversity, keystone species. Personalized plans available (diet, supplements, diary, recipes). EU lab + Maastricht University spin-off + GDPR-safe.
Get the latest gut-health tips and be the first to know about new collections and exclusive offers.